Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure

Kidney International

Volumn 59, Issue 6, 2001, Pages 2222-2232

  Rodríguez Iturbe, Bernardo ^a,b,c,d,e   Pons, Héctor ^a,b,c,d   Quiroz, Yasmir ^a,b,c,d   Gordon, Katherine ^a,b,c,d   Rincón, Jaimar ^a,b,c,d   Chávez, Maribel ^a,b,c,d   Parra, Gustavo ^a,b,c,d   Herrera Acosta, Jaime ^a,b,c,d   Gómez Garre, Dulcenombre ^a,b,c,d   Largo, Raquel ^a,b,c,d   Egido, Jesus ^a,b,c,d   Johnson, Richard J ^a,b,c,d  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d Nephrology   (Spain)

^e NONE   (Venezuela)

Author keywords

Blood pressure; Cell proliferation; Immune system; Immunosuppression; Mononuclear cell infiltrate; Rat experimental model; Renal interstitium

Indexed keywords

ANGIOTENSIN; INTERLEUKIN 2 RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; HYPERTENSION; IMMUNE SYSTEM; INTERSTITIAL NEPHRITIS; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SALT INTAKE; SODIUM ABSORPTION;

EID: 0035010673     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590062222.x     Document Type: Article

References (63)

1. Lombardi D, Gordon KL, Polinsky P, et al: Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension 33:1013-1019, 1999
2. Johnson RJ, Schreiner G: Hypothesis: Isessential hypertension an acquired tubulointerstitial renal disease? Kidney Int 52:1169-1179, 1997
3. Wilson C, Byrom FB: The vicious circle in chronic Bright's disease: Experimental evidence from the hypertensive rat. Q J Med 10:65-96, 1940
4. Eng E, Veniant M, Floege J, et al: Renal proliferation and phenotypic changes in rats with two-kidney one-clip Goldblatt hypertension. Am J Hypertens 7:177-185, 1994
5. Thomas SE, Anderson S, Gordon KL, et al: Tubulointerstitial disease in aging: Evidence for peritubular capillary damage: A potential role for renal ischemia. J Am Soc Nephrol 9:231-234, 1998
6. Pichler R, Franceshcini N, Young BA, et al: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
7. Johnson RJ, Gordon KL, Suga S, et al: Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension 34:151-159, 1999
8. 8. Schlöndorff D, Nelson PJ, Luckow B, Banas B: Chemokines and renal disease. Kidney Int 51:610-621, 1997
9. Bhagat K, Vallance P: Effects of cytokines on nitric oxide pathways in human vasculature. Curr Opin Nephrol Hypertens 8:89-96, 1999
10. Müller GA, Schettler V, Müller CA, Strutz F: Prevention of progression of renal fibrosis: How far are we? Kidney Int 49(Suppl 54):S75-S82, 1996
11. Allison AC, Eugui EM: Mycophenolatre mofetil a rationally designed immunosuppressive drug. Clin Transplant 7:96-112, 1993
12. Romero F, Rodríguez-Iturbe B. Parra G, et al: Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 55:945-955, 1999
13. Romero F, Rodríguez-Iturbe B, Pons H, et al: Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit. Atherosclerosis 152:127-133, 2000
14. Ziswiler R, Steiman-Niggli K, Kappeler A, et al: Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9:2055-2066, 1998
15. Hauser IA, Renders LO, Radeke H-H, et al: Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 14:58-63, 1999
16. Badid C, Vincent M, McGregor B, et al: Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 58:51-61, 2000
17. European Mycophenolate Mofetil Cooperative Study Group: Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 345:1321-1325, 1995
18. Johnson RJ, Alpers CE, Yoshimura A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
19. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-359, 1975
20. Parra G, Moreno P, Rodríguez-Iturbe B: Glomerular proliferative activity and T lymphocyte infiltration in acute serum sickness. Clin Immunol Immunopathol 82:299-302, 1997
21. Briggs RT, Robinson JM, Karnovsky ML, Karnovsky MJ: Super-oxide production by polymorphonuclear leukocytes: A cytochemical approach. Histochemistry 84:371-378, 1986
22. Rincón J, Parra G, Quiroz Y, Rodríguez-Iturbe B: Cyclosporine A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness. Clin Exp Immunol 121:391-398, 2000
23. Largo R, Gómez-Garre D, Soto K, et al: Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 33:732-739, 1999
24. Weiss S, Parker F: Pyelonephritis: Its relation to vascular lesions and to arterial hypertension. Medicine 18:221-316, 1939
25. Curtiss JJ, Luke RG, Jones P, Diethelm AG: Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med 85:134-138, 1988
26. Bennett W, Demattos A, Meyer M, et al: Chronic cyclosporin nephropathy: The Achilles's heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996
27. Fogo A, Breyere JA. Smith MC, et al: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) trial. Kidney Int 51:244-252, 1997
28. Gilbert ARE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int 56:1627-1637, 1999
29. Nadeau KC, Azuma H, Tilney NL: Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil. Transplantation 62:1363-1366, 1996
30. Durez P, Appelboom T, Pira C, et al: Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: Inhibition of TNF-alpha and upregulation of IL-10 release. Int J Immunopharmacol 21:581-587, 1999
31. Hildner K, Marker-Hermann E, Schlaak JE, et al: Azathioprine, mycophenolate mofetil and methotrexate specifically modulate cytokine production by T cells. Ann NY Acad Sci 859:204-207, 1998
32. Penny MJ, Boyd RA, Hall BM: Mycophenolate mofetil prevents the induction of active Heyman nephritis: Association with Th2 cytokine inhibition. J Am Soc Nephrol 9:2272-2282, 1998
33. Giachelli C, Pichler R, Lombardi DM, et al: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
34. Kleinman JG, Worcester EM, Beshensky AM, et al: Upregulation of osteopontin after acute ischemic injury in rats. Endocrinology 137:2133-2140, 1996
35. Von Thun AM, Veri R, El Dahr SS, Navar LG: Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol 266:F120-F128, 1994
36. Zhou L-X, Hymel A, Imig JD, Navar LG: Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension 27:658-662, 1996
37. Lombardi D, Viswanathan M, Vio CP, et al: Renal vascular injury induced by exogenous angiotensin II is AT1 receptor dependent. Nephron 87:66-74, 2001
38. Inagami T: Molecular biology and signaling of angiotensin receptors: An overview. J Am Soc Nephrol 10:S2-S7, 1999
39. Weinstock J, Kassab J: Functional angiotensin II receptors on macrophages from isolated liver granulomas of murine Schistosomiasis mansoni. J Immunol 132:2598-2601, 1984
40. Weinstock J, Blum A: Granuloma macrophages in immune Schistosomiasis mansoni generate components of the angiotensin system. Cell Immunol 89:39-45, 1984
41. Dezso B, Jacobsen J, Poulsen K: Evidence for the presence of angiotensins in normal, unstimulated, alveolar macrophages and monocytes. J Hypertens 7:5-11, 1989
42. Silverstein E, Pertschuk L, Friedland J: Immunofluorescence localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci USA 76:6646-6648, 1979
43. Rohrbach M, Conrad A: Comparison of the T lymphocyte-dependent of angiotensin-converting enzyme and leucine aminopeptidase in cultured human monocytes. Clin Exp Immunol 83:510-515, 1991
44. Ryu J, Vuk-Pavlovic Z, Rohrbach M: Monocyte heterogeneity in angiotensin-converting enzyme induction mediated by autologous T lymphocytes. Clin Exp Immunol 88:288-294, 1992
45. Lazarus D, Aschoff J, Fanburg B, Lancillo J: Angiotensin converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM- CSF but not by other cytokines. Biochem Biophys Acta 1226:12-18, 1994
46. Costerousse O, Allegrini J, López M, Alhenc-Gelás F: Angiotensin I-converting enzyme in human circulating mononuclear cells: Generic polymorphism of expression in T lymphocytes. Biochem J 290:33-44, 1993
47. Nataraj C, Oliveiro MI, Mannon RB, et al: Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 104:1693-1701, 1999
48. Ruiz-Ortega M, Bustos C, Hernández-Presa MA, et al: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161:430-439, 1998
49. Matsusaka T, Hymes J, Ichikawa I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 7:2025-2043, 1996
50. Rajagopalan S, Kurz S, Münzel T, et al: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923, 1996
51. Wang C-T, Chin SY, Navar GL: Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol 279:F325-F325, 2000
52. Cheng HF, Becker BN, Burus KD, Harris RC: Angiotensin II upregulates type-I angiotensin II receptors in renal proximal tubule. J Clin Invest 95:2012-2019, 1995
53. Wang DH, Du Y, Yao A, Hu Z: Regulation of type 1 angiotensin II receptor and its subtype gene expression in kidney by sodium loading and angiotensin II infusion. J Hypertens 14:1409-1415, 1996
54. Amiri F, García R: Differential regulation of renal glomerular and preglomerular vascular angiotensin II receptors. Am J Physiol 270:E810-E815, 1996
55. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG: Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 33:340-346, 1999
56. Tsutsumi K, Stromberg C, Saavedra J: Characterization of angiotensin II receptor subtypes in the rat spleen. Peptides 13:291-296, 1992
57. Ward RJ, Abiaka C, Peters TJ: Inflammation and tissue injury: The world of free radicals. J Nephrol 7:89-95, 1994
58. Swei A, Lacy F, Delano FA, Schmid-Schönbein GW: Oxidative stress in the Dahl hypertensive rat. Hypertension 30:1628-1633, 1997
59. Lacy F, O'Connor DT, Schmidt-Schönbein GW: Plasma hydrogen peroxide in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16:291-303, 1998
60. Verhagen AMG, Rabelink TJ, Braam B, et al: Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition. J Am Soc Nephrol 9:755-762, 1998
61. Oliveira M, Antunes E, De Nucci G, et al: Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 20:298-303, 1992
62. Abumiya T, Masuda J, Kawai J, et al. Heterogeneity in the appearance and distribution of macrophage subsets and their possible involvement in hypertensive vascular lesions in rats. Lab Invest 75:125-136, 1996
63. Kranzhöfer R, Browatzki M, Schmidt J, Kübler W: Angiotensin II activates the proinflamrnatory transcription factor nuclear factor kB in human monocytes. Biophys Res Commun 257:826-628, 1999